MedTwenty
Companies

Merck

This profile is still being built. It is not yet listed in the company index.

MedTwenty Indices and trackers are editorial indicators and business information. They are not investment, financial, legal or medical advice, and not a regulated benchmark.

Summary

Global pharmaceutical company, first to market with an oral PCSK9 inhibitor following FDA approval of Lipfendra.

Finances

Not published (small company accounts)

Timeline

No verified timeline entries yet.

MedTwenty coverage